Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder

Jack G. Modell, Joseph Himle, Randolph Nesse, James M. Mountz, Stephen Schmaltz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effects of fluoxetine, phenelzine, and tranylcypromine in obsessive-compulsive disorder (OCD) were compared in an open-label pilot study involving sequential treatment with these agents in six patients. Despite full (or maximally tolerated) trials on these medications, there was no improvement in OC symptoms referable to the pharmacotherapy. Three patients, however, subsequently showed major improvement in symptoms following application of behavioral therapy techniques. Despite the small sample size, this study suggests that there may be many patients with OCD for whom these medications might be poorly tolerated or ineffective, and emphasizes that behavioral-therapeutic techniques can be effective in patients for whom medications prove ineffective or intolerable. Of note, one patient displayed simultaneous manic and OC symptoms, thus undermining previous suggestions that the coexistence of these symptoms may not be possible.

Original languageEnglish (US)
Pages (from-to)287-293
Number of pages7
JournalJournal of Anxiety Disorders
Volume3
Issue number4
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Phenelzine
Tranylcypromine
Fluoxetine
Obsessive-Compulsive Disorder
Therapeutics
Sample Size
Drug Therapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. / Modell, Jack G.; Himle, Joseph; Nesse, Randolph; Mountz, James M.; Schmaltz, Stephen.

In: Journal of Anxiety Disorders, Vol. 3, No. 4, 1989, p. 287-293.

Research output: Contribution to journalArticle

Modell, Jack G. ; Himle, Joseph ; Nesse, Randolph ; Mountz, James M. ; Schmaltz, Stephen. / Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder. In: Journal of Anxiety Disorders. 1989 ; Vol. 3, No. 4. pp. 287-293.
@article{a1ab8347e7774b3ea2cbf39f9fde6be0,
title = "Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder",
abstract = "The effects of fluoxetine, phenelzine, and tranylcypromine in obsessive-compulsive disorder (OCD) were compared in an open-label pilot study involving sequential treatment with these agents in six patients. Despite full (or maximally tolerated) trials on these medications, there was no improvement in OC symptoms referable to the pharmacotherapy. Three patients, however, subsequently showed major improvement in symptoms following application of behavioral therapy techniques. Despite the small sample size, this study suggests that there may be many patients with OCD for whom these medications might be poorly tolerated or ineffective, and emphasizes that behavioral-therapeutic techniques can be effective in patients for whom medications prove ineffective or intolerable. Of note, one patient displayed simultaneous manic and OC symptoms, thus undermining previous suggestions that the coexistence of these symptoms may not be possible.",
author = "Modell, {Jack G.} and Joseph Himle and Randolph Nesse and Mountz, {James M.} and Stephen Schmaltz",
year = "1989",
doi = "10.1016/0887-6185(89)90019-4",
language = "English (US)",
volume = "3",
pages = "287--293",
journal = "Journal of Anxiety Disorders",
issn = "0887-6185",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Sequential trials of fluoxetine, phenelzine, and tranylcypromine in the treatment of obsessive-compulsive disorder

AU - Modell, Jack G.

AU - Himle, Joseph

AU - Nesse, Randolph

AU - Mountz, James M.

AU - Schmaltz, Stephen

PY - 1989

Y1 - 1989

N2 - The effects of fluoxetine, phenelzine, and tranylcypromine in obsessive-compulsive disorder (OCD) were compared in an open-label pilot study involving sequential treatment with these agents in six patients. Despite full (or maximally tolerated) trials on these medications, there was no improvement in OC symptoms referable to the pharmacotherapy. Three patients, however, subsequently showed major improvement in symptoms following application of behavioral therapy techniques. Despite the small sample size, this study suggests that there may be many patients with OCD for whom these medications might be poorly tolerated or ineffective, and emphasizes that behavioral-therapeutic techniques can be effective in patients for whom medications prove ineffective or intolerable. Of note, one patient displayed simultaneous manic and OC symptoms, thus undermining previous suggestions that the coexistence of these symptoms may not be possible.

AB - The effects of fluoxetine, phenelzine, and tranylcypromine in obsessive-compulsive disorder (OCD) were compared in an open-label pilot study involving sequential treatment with these agents in six patients. Despite full (or maximally tolerated) trials on these medications, there was no improvement in OC symptoms referable to the pharmacotherapy. Three patients, however, subsequently showed major improvement in symptoms following application of behavioral therapy techniques. Despite the small sample size, this study suggests that there may be many patients with OCD for whom these medications might be poorly tolerated or ineffective, and emphasizes that behavioral-therapeutic techniques can be effective in patients for whom medications prove ineffective or intolerable. Of note, one patient displayed simultaneous manic and OC symptoms, thus undermining previous suggestions that the coexistence of these symptoms may not be possible.

UR - http://www.scopus.com/inward/record.url?scp=0024415395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024415395&partnerID=8YFLogxK

U2 - 10.1016/0887-6185(89)90019-4

DO - 10.1016/0887-6185(89)90019-4

M3 - Article

AN - SCOPUS:0024415395

VL - 3

SP - 287

EP - 293

JO - Journal of Anxiety Disorders

JF - Journal of Anxiety Disorders

SN - 0887-6185

IS - 4

ER -